Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy.
Reid
B A
BA
Department of Obstetrics and Gynaecology, St. Mary's Hospital, London, UK.
Gangar
K F
KF
Beard
R W
RW
D000328:Adult; D002064:Buserelin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy*; D015914:Estrogen Replacement Therapy / Q000379:methods*; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D017273:Goserelin; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D010386:Pelvic Neoplasms / Q000188:drug therapy*
D004966:Estrogens, Conjugated (USP); D017273:Goserelin; D008525:Medroxyprogesterone; D002064:Buserelin